Going Out With a Bang--An Interview with Ron Dollens
Executive Summary
Few companies have achieved the kinds of success that Guidant Corp. has in its ten years in existence and few executives have had the impact on the medical device space that Ron Dollens, Guidant's CEO, has had. In this interview, adapted from the Stanford BioDesign Program's "From the Innovator's Work Bench" series, Dollens talks about his career and about the success Guidant has had.
You may also be interested in...
Beyond Medical Devices: An Interview with Medtronic's Bill Hawkins
In a career that has spanned more than 20 years, Bill Hawkins has worked for a wide array of medical device firms, leaving his imprint on this industry. Now, as Medtronic's COO, his influence will only grow. In this interview, Hawkins talks about the history of the device industry and what lies ahead.
US Q1 Consumer Health Earnings Preview: Label This One Historic And Challenging But Promising
US OTC drug and supplement firms’ reports of results for the first three months of 2024 began on April 19 with P&G. JP Morgan analysts say while “some retailers in the US in particular” are reducing consumer health inventories, for the overall sector they expect “a healthier balance of positive volume and lower pricing contribution.”
Keeping Track: Cancer Approvals From Lumisight Imaging To Adjuvant Alecensa
The US FDA’s approval of Lumicell’s optical imaging agent Lumisight makes a dozen novel approvals in 2024 for the Center for Drug Evaluation and Research.